Lexeo Therapeutics Inc (LXEO)

EBITDA Growth

0.93%

Quarterly · Period ending:

LXEO logo

LXEO EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported0.93%
LXEO Quarterly EBITDA YoY % (-45.13% → 0.93%)
High-resolution chart · PNG

LXEO ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
0.9282%
38.8666%
19.773%
32.0401%
-23.311%
-51.7077%
-85.9236%
-47.7087%
-59.9985%
-16.5694%
3.0615%
-17.4538%
12.4517%
-45.1342%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.